Search details
1.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38517658
2.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38494578
3.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38353907
4.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38649648
5.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38526621
6.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38538963
7.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38578596
8.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38696053
9.
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations.
JTO Clin Res Rep
; 2(1): 100107, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-34589972
10.
Progress of oral care and reduction of oral mucositis--a pilot study in a hematopoietic stem cell transplantation ward.
Support Care Cancer
; 19(2): 303-7, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-20842384
11.
Oral mucositis in patients receiving reduced-intensity regimens for allogeneic hematopoietic cell transplantation: comparison with conventional regimen.
Support Care Cancer
; 18(1): 115-9, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19387694
12.
A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors.
J Pharm Health Care Sci
; 4: 2, 2018.
Article
in English
| MEDLINE | ID: mdl-29375887
13.
Association of serum total bilirubin with renal outcome in Japanese patients with stages 3-5 chronic kidney disease.
Metabolism
; 64(9): 1096-102, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26142826
14.
Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis.
Hypertens Res
; 37(12): 1050-5, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25056682
Results
1 -
14
de 14
1
Next >
>>